Your session is about to expire
← Back to Search
D-cycloserine for Lower Back Pain
Study Summary
This trial is testing whether a drug called D-cycloserine can help people with chronic lower back pain.
- Lower Back Pain
- Pain
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 4 trial • 8 Patients • NCT01833897Trial Design
Who is running the clinical trial?
Media Library
- I'm sorry, but this is not a complete criterion. Could you please provide more information about what you are referring to?This screening criteria is incomplete and requires more information to accurately summarize. Please provide additional details.You are currently taking medication to relax your muscles.You are taking gabapentin, pregabalin or other similar medications.You are not allowed to take any pain-relieving medications, including those that can be bought without a prescription.You should not take non-steroidal anti-inflammatory drugs (NSAIDs), including over-the-counter (OTC) medications.
- Group 1: D-cycloserine
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people fit the criteria to participate in this clinical trial?
"That is correct. The listing on clinicaltrials.gov does show that the trial administrators are still looking for patients to enroll. This particular trial was posted on March 30th, 2018 and updated January 6th, 2022. They are hoping to have 244 people participate at one location."
Will D-cycloserine have any negative consequences for test subjects?
"D-cycloserine has received a safety score of 2. This is because, although there is evidence that it is safe, there have been no clinical trials demonstrating its efficacy."
How does D-cycloserine usually help patients?
"D-cycloserine is often used to treat patients that have failed to respond to conventional therapies. It can also be an effective way of treating other conditions such as tuberculosis, extrapulmonary tuberculosis, and pulmonary tuberculosis."
What other scientific papers feature D-cycloserine?
"Currently, there are 9 D-cycloserine studies underway. 2 of those trials have progressed to Phase 3 clinical testing. The great majority of these tests are taking place in Baltimore, MD; however, 23 sites across the country are running similar investigations."
Are there any available vacancies for people who want to participate in this experiment?
"That is correct, the clinicaltrials.gov website has information indicating that this study is still looking for participants. The trial was originally posted on March 30th, 2018 and updated January 6th, 2022. They are currently seeking 244 patients from 1 site."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Average response time
- < 1 Day
Typically responds via
Most responsive sites:
- Northwestern University Feinberg School of Medicine: < 24 hours
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger